CRV (Charles River Ventures) — 2015 Investments
3 investments dated 2015 · listed companies and verified rows first · show all
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon
Riley Ennis(Co-Founder and Chief Product Officer)Charles Roberts(Director)inGabriel Otte(Director)in
BoardStuart Lawson(Director)
Co-investorsRA CapitalAME Cloud VenturesAndreessen HorowitzArtis VenturesAsset Management CompanyAverin Capital+8 more
San Francisco, US
SAM LAWRENCE(Executive Officer, Director)
BoardCHAMATH PALIHAPITIYA(Director)DAVID HERSH(Director)MATT WILKINSON(Director)
Board seatGeorge Zachary· per SEC Form D · $4M raise · filed Feb 2015
Co-investorsSocial Capital Partnership
Toronto
Rebecca Skvorc(Vice President, Finance)Mamoon Hamid(Director)James Lochrie(Vice President, Chief Technology Officer and Director)Kirk Simpson(President, CEO and Director)
BoardKevin Kimsa(Director)in
Board seatDevdutt Yellurkar· per SEC Form D · $14M raise · filed May 2015
Co-investorsClimate Innovation CapitalFramework Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.